Comparison Chart Palvella Therapeutics, Inc.
Stocks
PVLA
US6979471090
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:00:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 175.92 USD | +12.16% |
|
+20.37% | +68.07% |
| 11-06 | Oppenheimer Adjusts Palvella Therapeutics Price Target to $232 From $210, Maintains Outperform Rating | MT |
| 11-05 | Palvella Therapeutics Shares Drop After Q3 Net Loss Widens | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. | Bio Therapeutic Drugs | +12.16% | +20.37% | +68.07% | +123.73% | - | 2.53B |  | | |
- Stock Market
- Stocks
- PVLA Stock
- Charts Palvella Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
